Select Publications

Journal articles

Liu D; Gunther K; Enriquez LA; Daniels B; O’Mara TA; Tang K; Spurdle AB; Ford CE, 2022, 'Author Correction: ROR1 is upregulated in endometrial cancer and represents a novel therapeutic target (Scientific Reports, (2020), 10, 1, (13906), 10.1038/s41598-020-70924-z)', Scientific Reports, vol. 12, pp. 10918, http://dx.doi.org/10.1038/s41598-022-15043-7

Lopez D; Strange C; Sanfilippo F; Daniels B; Pearson S; Preen D, 2022, 'Priorities for building Australian workforce capacity to leverage population-based, routinely collected data: views from pharmacoepidemiology.', Public Health Res Pract, http://dx.doi.org/10.17061/phrp32122206

Daniels B; Schaffer A; Buckley NA; Bruno C; Jun M; Pearson SA; Zoega H, 2022, 'The impact of tightened prescribing restrictions on proton pump inhibitor use in Australia: An evaluation using interrupted time series analysis', Pharmacoepidemiology and Drug Safety, vol. 31, pp. 370 - 378, http://dx.doi.org/10.1002/pds.5395

Lord SJ; Bahlmann K; O'Connell DL; Kiely BE; Daniels B; Pearson SA; Beith J; Bulsara MK; Houssami N, 2022, 'De novo and recurrent metastatic breast cancer – A systematic review of population-level changes in survival since 1995', eClinicalMedicine, vol. 44, http://dx.doi.org/10.1016/j.eclinm.2022.101282

Hong S; Daniels B; van Leeuwen MT; Pearson SA; Vajdic CM, 2022, 'Incidence and risk factors of hypertension therapy in Australian cancer patients treated with vascular signalling pathway inhibitors', Discover Oncology, vol. 13, http://dx.doi.org/10.1007/s12672-022-00468-3

Daniels B; Havard A; Myton R; Lee C; Chidwick K, 2022, 'Evaluating the accuracy of data extracted from electronic health records into MedicineInsight, a national Australian general practice database', International Journal of Population Data Science, vol. 7, http://dx.doi.org/10.23889/IJPDS.V7I1.1713

Daniels B; Healey P; Bruno C; Kaan I; Zoega H, 2021, 'Medicine treatment of glaucoma in Australia 2012-2019: Prevalence, incidence and persistence', BMJ Open Ophthalmology, vol. 6, http://dx.doi.org/10.1136/bmjophth-2021-000921

Havard A; Manski-Nankervis JA; Thistlethwaite J; Daniels B; Myton R; Tu K; Chidwick K, 2021, 'Validity of algorithms for identifying five chronic conditions in MedicineInsight, an Australian national general practice database', BMC Health Services Research, vol. 21, pp. 551, http://dx.doi.org/10.1186/s12913-021-06593-z

Tadrous M; Daniels B; Pearson SA; Gomes T, 2021, 'Comparison of claims from high-drug cost beneficiaries in Ontario, Canada, and Australia: a cross-sectional analysis', CMAJ open, vol. 9, pp. E1048 - E1054, http://dx.doi.org/10.9778/cmajo.20200291

Busingye D; Daniels B; Brett J; Pollack A; Belcher J; Chidwick K; Blogg S, 2021, 'Patterns of real-world opioid prescribing in Australian general practice (2013-18)', Australian Journal of Primary Health, vol. 27, pp. 416 - 424, http://dx.doi.org/10.1071/PY20270

Tang M; Daniels B; Aslam M; Schaffer A; Pearson SA, 2021, 'Changes in systemic cancer therapy in Australia during the COVID-19 pandemic: a population-based study', The Lancet Regional Health - Western Pacific, vol. 14, http://dx.doi.org/10.1016/j.lanwpc.2021.100226

Tang M; Daniels B; Schaffer AL; Pearson SA, 2021, 'Real-world data to advance HER2-targeted cancer medicines research: Playing to the strengths of clinical registry and administrative data', Asia-Pacific Journal of Clinical Oncology, vol. 17, pp. 414 - 415, http://dx.doi.org/10.1111/ajco.13554

Daniels B; Kiely BE; Tang M; Houssami N; Lord SJ; Pearson SA, 2021, 'Trastuzumab emtansine for HER2-positive metastatic breast cancer: Outcomes from a whole-of-population Australian cohort', Breast, vol. 58, pp. 106 - 112, http://dx.doi.org/10.1016/j.breast.2021.05.001

Tang M; Schaffer AL; Kiely BE; Daniels B; Lee CK; Simes RJ; Pearson SA, 2021, 'Cardiac assessment in Australian patients receiving (neo)adjuvant trastuzumab for HER2-positive early breast cancer: a population-based study', Breast Cancer Research and Treatment, vol. 187, pp. 893 - 902, http://dx.doi.org/10.1007/s10549-021-06135-5

Brett J; Pearson SA; Daniels B; Wylie CE; Buckley NA, 2021, 'A cross sectional study of psychotropic medicine use in Australia in 2018: A focus on polypharmacy', British Journal of Clinical Pharmacology, vol. 87, pp. 1369 - 1377, http://dx.doi.org/10.1111/bcp.14527

Falster MO; Charrier R; Pearson SA; Buckley NA; Daniels B, 2021, 'Long-term trajectories of medicine use among older adults experiencing polypharmacy in Australia', British Journal of Clinical Pharmacology, vol. 87, pp. 1264 - 1274, http://dx.doi.org/10.1111/bcp.14504

Daniels B; Luckett T; Holliday S; Liauw W; Lovell M; Phillips J; Rowett D; John TN; Tervonen H; Pearson SA, 2021, 'Patterns of oxycodone controlled release use in older people with cancer following public subsidy of oxycodone/naloxone formulations: An Australian population-based study', Asia-Pacific Journal of Clinical Oncology, vol. 17, pp. 68 - 78, http://dx.doi.org/10.1111/ajco.13408

Daniels B; Pearson SA; Buckley NA; Bruno C; Schaffer A; Zoega H, 2021, 'Coming to grips with seemingly conflicting results in programme evaluation: The devil's in the detail', BMJ Quality and Safety, vol. 30, pp. 70 - 71, http://dx.doi.org/10.1136/bmjqs-2020-012118

Liu D; Gunther K; Enriquez LA; Daniels B; O’Mara TA; Tang K; Spurdle AB; Ford CE, 2020, 'ROR1 is upregulated in endometrial cancer and represents a novel therapeutic target', Scientific Reports, vol. 10, pp. 13906, http://dx.doi.org/10.1038/s41598-020-70924-z

Daniels B; Pearson SA; Vajdic CM; Pottegård A; Buckley NA; Zoega H, 2020, 'Risk of squamous cell carcinoma of the lip and cutaneous melanoma in older Australians using hydrochlorothiazide: A population-based case-control study', Basic and Clinical Pharmacology and Toxicology, vol. 127, pp. 320 - 328, http://dx.doi.org/10.1111/bcpt.13463

Wylie CE; Daniels B; Brett J; Pearson SA; Buckley NA, 2020, 'A national study on prescribed medicine use in Australia on a typical day', Pharmacoepidemiology and Drug Safety, vol. 29, pp. 1046 - 1053, http://dx.doi.org/10.1002/pds.5093

Tang M; Schaffer A; Kiely BE; Daniels B; Simes RJ; Lee CK; Pearson SA, 2020, 'Correction: Treatment patterns and survival in HER2-positive early breast cancer: a whole-of-population Australian cohort study (2007–2016) (British Journal of Cancer, (2019), 121, 11, (904-911), 10.1038/s41416-019-0612-5)', British Journal of Cancer, vol. 123, pp. 868, http://dx.doi.org/10.1038/s41416-020-0908-5

Homaira N; Daniels B; Pearson S; Jaffe A, 2020, 'Dispensing practices of fixed dose combination controller therapy for asthma in australian children and adolescents', International Journal of Environmental Research and Public Health, vol. 17, pp. 1 - 7, http://dx.doi.org/10.3390/ijerph17165645

Zheng D; Brett J; Daniels B; Buckley NA; Pearson SA; Schaffer AL, 2020, 'Potentially inappropriate benzodiazepine use in Australian adults: A population-based study (2014–2017)', Drug and Alcohol Review, vol. 39, pp. 575 - 582, http://dx.doi.org/10.1111/dar.13086

Favell DL; Tang M; Daniels B; Vajdic CM; Zoega H; Pearson SA, 2020, 'Capture of systemic anticancer medicines in pharmaceutical benefits scheme (PBS) data likely higher than previously reported', Public Health Research and Practice, vol. 30, http://dx.doi.org/10.17061/phrp3022013

Wu J; Dickinson S; Elgebaly Z; Blogg S; Heaney A; Soo Y; Daniels B; Weekes L, 2020, 'Impact of NPS MedicineWise general practitioner education programs and Choosing Wisely Australia recommendations on prescribing of proton pump inhibitors in Australia', BMC Family Practice, vol. 21, pp. 85, http://dx.doi.org/10.1186/s12875-020-01158-1

Bruno C; Pearson SA; Daniels B; Buckley NA; Schaffer A; Zoega H, 2020, 'Passing the acid test? Evaluating the impact of national education initiatives to reduce proton pump inhibitor use in Australia', BMJ Quality and Safety, vol. 29, pp. 365 - 373, http://dx.doi.org/10.1136/bmjqs-2019-009897

Daniels B; Tervonen HE; Pearson SA, 2020, 'Identifying incident cancer cases in dispensing claims: A validation study using Australia's Repatriation Pharmaceutical Benefits Scheme (PBS) data', International Journal of Population Data Science, vol. 5, http://dx.doi.org/10.23889/ijpds.v5i1.1152

Daniels B; Pearson SA; Buckley NA; Bruno C; Zoega H, 2020, 'Long-term use of proton-pump inhibitors: whole-of-population patterns in Australia 2013–2016', Therapeutic Advances in Gastroenterology, vol. 13, http://dx.doi.org/10.1177/1756284820913743

Coleman L; Brett J; Daniels B; Pearson S; Falster M, 2020, 'Medicine reviews: do they reduce benzodiazepine use in older Australians?', Public Health Research & Practice, http://dx.doi.org/10.17061/phrp30452015

Tang M; Schaffer A; Kiely BE; Daniels B; Simes RJ; Lee CK; Pearson SA, 2019, 'Treatment patterns and survival in HER2-positive early breast cancer: a whole-of-population Australian cohort study (2007–2016)', British Journal of Cancer, vol. 121, pp. 904 - 911, http://dx.doi.org/10.1038/s41416-019-0612-5

Daniels B; Kiely BE; Tang M; Tervonen H; Pearson SA, 2019, 'Trastuzumab use in older patients with HER2-positive metastatic breast cancer: Outcomes and treatment patterns in a whole-of-population Australian cohort (2003-2015)', BMC Cancer, vol. 19, http://dx.doi.org/10.1186/s12885-019-6126-y

Lord SJ; Kiely BE; Pearson SA; Daniels B; O'Connell DL; Beith J; Bulsara MK; Houssami N, 2019, 'Metastatic breast cancer incidence, site and survival in Australia, 2001-2016: A population-based health record linkage study protocol', BMJ Open, vol. 9, http://dx.doi.org/10.1136/bmjopen-2018-026414

Tervonen HE; Daniels B; Tang M; Preen DB; Pearson SA, 2019, 'Patterns of endocrine therapy in a national cohort of early stage HER2-positive breast cancer patients', Pharmacoepidemiology and Drug Safety, http://dx.doi.org/10.1002/pds.4751

Brett J; Zoega H; Buckley NA; Daniels BJ; Elshaug AG; Pearson SA, 2018, 'Choosing wisely? Quantifying the extent of three low value psychotropic prescribing practices in Australia', BMC Health Services Research, vol. 18, pp. 1009, http://dx.doi.org/10.1186/s12913-018-3811-5

Tan SYS; O’Neill S; Goldstein D; Ward RL; Daniels B; Vajdic CM, 2018, 'Predictors of care for patients with cancer of unknown primary site in three Australian hospitals', Asia-Pacific Journal of Clinical Oncology, vol. 14, pp. e512 - e520, http://dx.doi.org/10.1111/ajco.12815

Lopez D; Daniels B; Sanfilippo F; Pearson S; Martini A; Preen DB, 2018, 'Needs and priority areas for building capacity for working with linked data in the Australian pharmacoepidemiology workforce', International Journal of Population Data Science, vol. 3, http://dx.doi.org/10.23889/ijpds.v3i4.733

Daniels B; Kiely BE; Lord SJ; Houssami N; Lu CY; Ward RL; Pearson SA, 2018, 'Long-term survival in trastuzumab-treated patients with HER2-positive metastatic breast cancer: real-world outcomes and treatment patterns in a whole-of-population Australian cohort (2001–2016)', Breast Cancer Research and Treatment, vol. 171, pp. 151 - 159, http://dx.doi.org/10.1007/s10549-018-4804-0

Daniels B; Girosi F; Tervonen H; Kiely BE; Lord SJ; Houssami N; Pearson SA, 2018, 'Adherence to prescribing restrictions for her2-positive metastatic breast cancer in Australia: A national population-based observational study (2001-2016)', PLoS ONE, vol. 13, http://dx.doi.org/10.1371/journal.pone.0198152

Daniels B; Kiely BE; Lord SJ; Houssami N; Lu CY; Ward RL; Pearson SA, 2018, 'Trastuzumab for metastatic breast cancer: Real world outcomes from an Australian whole-of-population cohort (2001–2016)', Breast, vol. 38, pp. 7 - 13, http://dx.doi.org/10.1016/j.breast.2017.11.007

Henry CE; Llamosas E; Daniels B; Coopes A; Tang K; Ford CE, 2018, 'ROR1 and ROR2 play distinct and opposing roles in endometrial cancer', Gynecologic Oncology, vol. 148, pp. 576 - 584, http://dx.doi.org/10.1016/j.ygyno.2018.01.025

Daniels B; Kiely BE; Houssami N; Lord SJ; Dobbins T; Lu CY; Ward RL; Pearson SA, 2018, 'Survival outcomes for Australian women receiving trastuzumab for HER2-positive metastatic breast cancer following (neo)adjuvant trastuzumab: A national population-based observational study (2006-2014)', British Journal of Cancer, vol. 118, pp. 441 - 447, http://dx.doi.org/10.1038/bjc.2017.405

Harris CA; Daniels BJ; Ward RL; Pearson SA, 2017, 'Retrospective comparison of Australia’s Pharmaceutical Benefits Scheme claims data with prescription data in HER2 positive early breast cancer patients (2008-2012)', Public Health Research and Practice, vol. 27, http://dx.doi.org/10.17061/phrp2751744

Brett J; Daniels B; Karanges EA; Buckley NA; Schneider C; Nassir A; McLachlan AJ; Pearson SA, 2017, 'Psychotropic polypharmacy in Australia, 2006 to 2015: a descriptive cohort study', British Journal of Clinical Pharmacology, vol. 83, pp. 2581 - 2588, http://dx.doi.org/10.1111/bcp.13369

Brett J; Karanges EA; Daniels B; Buckley NA; Schneider C; Nassir A; Zoega H; McLachlan AJ; Pearson SA, 2017, 'Psychotropic medication use in Australia, 2007 to 2015: Changes in annual incidence, prevalence and treatment exposure', Australian and New Zealand Journal of Psychiatry, vol. 51, pp. 990 - 999, http://dx.doi.org/10.1177/0004867417721018

Daniels B; Lord SJ; Kiely BE; Houssami N; Haywood P; Lu CY; Ward RL; Pearson SA, 2017, 'Use and outcomes of targeted therapies in early and metastatic HER2-positive breast cancer in Australia: Protocol detailing observations in a whole of population cohort', BMJ Open, vol. 7, http://dx.doi.org/10.1136/bmjopen-2016-014439

Ma SSQ; Henry CE; Llamosas E; Higgins R; Daniels B; Hesson LB; Hawkins NJ; Ward RL; Ford CE, 2017, 'Validation of specificity of antibodies for immunohistochemistry: the case of ROR2', Virchows Archiv : an international journal of pathology, vol. 470, pp. 99 - 108, http://dx.doi.org/10.1007/s00428-016-2019-5

Ma SSQ; Henry CE; Llamosas E; Higgins R; Daniels B; Hesson LB; Hawkins NJ; Ward RL; Ford CE, 2016, 'Erratum to: Validation of specificity of antibodies for immunohistochemistry: the case of ROR2 (Virchows Archiv, (2016), 10.1007/s00428-016-2019-5)', Virchows Archiv, vol. 469, pp. 717, http://dx.doi.org/10.1007/s00428-016-2036-4

Vajdic CM; Mayson E; Dodds AJ; O'Brien T; Wilcox L; Nivison-Smith I; Le Marsney R; Daniels B; Ashton LJ; Tan J; Bilmon I; Aarons D; Tran S; Gibson J; Johnston A; Greenwood M; Forbes M; Hertzberg M; Huang G; Spencer A; Muirhead J; Szer J; Mason K; Lewis I; To C; Durrant S; Western R; Cannell P; Buffery S; Oswald C; Nelson A; Shaw P; Pearson L; Tiedemann K; Scoyne M; Fraser C; Seljak J; Cole C; Rowland K; Gough H; Tapp H; Green N; Moa A; McRae J; Jenkins M; Hicks J; Chaplin K, 2016, 'Second Cancer Risk and Late Mortality in Adult Australians Receiving Allogeneic Hematopoietic Stem Cell Transplantation: A Population-Based Cohort Study', Biology of Blood and Marrow Transplantation, vol. 22, pp. 949 - 956, http://dx.doi.org/10.1016/j.bbmt.2016.01.027

Cairns R; Daniels B; Wood DA; Brett J, 2016, 'ADHD medication overdose and misuse: The NSW poisons information centre experience, 2004-2014', Medical Journal of Australia, vol. 204, pp. 154.e1 - 154.e7, http://dx.doi.org/10.5694/mja15.00791


Back to profile page